Amphastar Pharmaceuticals, Inc. (AMPH)
19.00
-5.03
(-20.93%)
USD |
NASDAQ |
May 08, 16:00
19.00
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals EPS Diluted (Quarterly) : 0.1382 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -0.0398 |
| Amneal Pharmaceuticals, Inc. | 0.1893 |
| Organon & Co. | 0.5554 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.42M |
| Revenue (Quarterly) | 171.17M |
| Total Expenses (Quarterly) | 164.75M |
| Enterprise Value | 1.230B |
| Gross Profit Margin (Quarterly) | 38.84% |
| Profit Margin (Quarterly) | 3.75% |
| Earnings Yield | 8.76% |
| Operating Earnings Yield | 12.97% |
| Normalized Earnings Yield | 8.038 |